Therapy: Targeting MYC? You BET

Nature Reviews Cancer

Volumn 11, Issue 10, 2011, Pages 693-

  Alderton, Gemma K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

JQ1; PROTEIN BET; PROTEIN BRD4; PROTEIN INHIBITOR; REGULATOR PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CHROMATIN; DRUG MECHANISM; DRUG TARGETING; MULTIPLE MYELOMA; NONHUMAN; NOTE; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 80053135617     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3147     Document Type: Note

References (1)

1. Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 1 Sep 2011 (doi:10.1016/j.cell.2011.08.017)